Adverum Biotechnologies (ADVM) Earnings Date, Estimates & Call Transcripts $3.49 +0.16 (+4.80%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$3.49 0.00 (0.00%) As of 05/2/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Adverum Biotechnologies Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Apr. 15) -$1.34 Actual EPS (Apr. 15) -$1.96 Missed By -$0.62 Adverum Biotechnologies issued Q4 2024 earnings on April 15, 2025, reporting an EPS of -$1.96, which missed analysts' consensus estimates of -$1.34 by $0.62. With a trailing EPS of -$5.65, Adverum Biotechnologies' earnings are expected to decrease next year, from ($4.92) to ($5.20) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)ADVM Upcoming EarningsAdverum Biotechnologies' Q4 2024 earnings is scheduled for Thursday, May 8, 2025Powered by Get Adverum Biotechnologies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adverum Biotechnologies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataADVM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADVM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Adverum Biotechnologies Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($4.92) EPSNext Year EPS Consensus Estimate ($5.20) EPS Adverum Biotechnologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--------4/15/2025Q4 2024-$1.34-$1.96 -$0.62-$1.96--11/4/2024--$1.20-$1.30 -$0.10-$1.30$0.50M$1.00M8/12/2024Q2 2024-$1.47-$0.89+$0.58-$0.89$0.53M-5/9/2024Q1 2024-$1.28-$1.50 -$0.22-$1.50--3/18/2024Q4 2023-$2.80-$2.30+$0.50-$2.30--11/9/2023Q3 2023-$3.00-$3.30 -$0.30-$0.33--8/10/2023Q2 2023-$3.20-$3.10+$0.10-$0.31--5/11/2023Q1 2023-$3.00-$2.90+$0.10-$0.29-$3.60M Adverum Biotechnologies Earnings - Frequently Asked Questions When is Adverum Biotechnologies's earnings date? Adverum Biotechnologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on ADVM's earnings history. Did Adverum Biotechnologies beat their earnings estimates last quarter? In the previous quarter, Adverum Biotechnologies (NASDAQ:ADVM) missed the analysts' consensus estimate of ($1.34) by $0.62 with a reported earnings per share (EPS) of ($1.96). Learn more on analysts' earnings estimate vs. ADVM's actual earnings. How much revenue does Adverum Biotechnologies generate each year? Adverum Biotechnologies (NASDAQ:ADVM) has a recorded annual revenue of $1 million. How much profit does Adverum Biotechnologies generate each year? Adverum Biotechnologies (NASDAQ:ADVM) has a recorded net income of -$117.17 million. ADVM has generated -$5.65 earnings per share over the last four quarters. What is Adverum Biotechnologies's EPS forecast for next year? Adverum Biotechnologies's earnings are expected to decrease from ($4.92) per share to ($5.20) per share in the next year. More Earnings Resources from MarketBeat Related Companies Lifecore Biomedical Earnings Date Corvus Pharmaceuticals Earnings Date Candel Therapeutics Earnings Date Design Therapeutics Earnings Date Cidara Therapeutics Earnings Date enGene Earnings Date Rezolute Earnings Date Bright Minds Biosciences Earnings Date Humacyte Earnings Date Protalix BioTherapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:ADVM) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adverum Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADVM Stock Free ADVM Stock Alerts